Kyle Malady, Director at DEXCOM INC (DXCM), sold 1,334 shares at $80.86 ($108K) on 2025-09-05, disclosed to the SEC on 2025-09-09.
Scheduled sale ($108k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.86 | 667 | $54K | 50.0% |
| 2 | $80.86 | 667 | $54K | 50.0% |
| Total | $80.86 avg | 1,334 | $108K | 100% |
| Filing → |
| VZ | SELL | 2026-09-23 | $52K | — | Filing → |
| VZ | SELL | 2026-09-16 | $56K | — | Filing → |
| VZ | SELL | 2026-09-09 | $55K | — | Filing → |